| Dr Marian Roberta-bentley Fuller, MD | |
|
1293 E Parkdale Ave, Manistee, MI 49660 | |
| (231) 398-1550 | |
| Not Available |
| Full Name | Dr Marian Roberta-bentley Fuller |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 1293 E Parkdale Ave, Manistee, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225053366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301079496 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Healthcare Manistee Hospital | Manistee, MI | Hospital |
| Spectrum Health Ludington Hospital | Ludington, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Healthcare Manistee Hospital | 3072414333 | 20 |
News Archive
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
Nearly 70,000 people worldwide are living with cystic fibrosis, a life-threatening genetic disease. There currently is no cure for the condition, but researchers from the University of Missouri have identified a key component in the protein that causes the disease. It is a finding that may lay the foundation for the development of new medications and improved therapies.
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 1 days ago
| Entity Name | Munson Healthcare Manistee Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649457771 PECOS PAC ID: 3072414333 Enrollment ID: O20040119000647 |
News Archive
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
Nearly 70,000 people worldwide are living with cystic fibrosis, a life-threatening genetic disease. There currently is no cure for the condition, but researchers from the University of Missouri have identified a key component in the protein that causes the disease. It is a finding that may lay the foundation for the development of new medications and improved therapies.
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 1 days ago
| Entity Name | Munson Healthcare Charlevoix Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629154307 PECOS PAC ID: 4284528035 Enrollment ID: O20071011000237 |
News Archive
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
Nearly 70,000 people worldwide are living with cystic fibrosis, a life-threatening genetic disease. There currently is no cure for the condition, but researchers from the University of Missouri have identified a key component in the protein that causes the disease. It is a finding that may lay the foundation for the development of new medications and improved therapies.
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marian Roberta-bentley Fuller, MD 1293 E Parkdale Ave, Manistee, MI 49660-8904 Ph: (231) 398-1550 | Dr Marian Roberta-bentley Fuller, MD 1293 E Parkdale Ave, Manistee, MI 49660 Ph: (231) 398-1550 |
News Archive
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
Nearly 70,000 people worldwide are living with cystic fibrosis, a life-threatening genetic disease. There currently is no cure for the condition, but researchers from the University of Missouri have identified a key component in the protein that causes the disease. It is a finding that may lay the foundation for the development of new medications and improved therapies.
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 1 days ago
Ronald Roger Joanette, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1293 E. Parkdale Avenue, Suite 1200a, Manistee, MI 49660 Phone: 231-398-1550 Fax: 231-398-1691 | |
Dr. Stephanie Lynne Fitzgerald, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1293 E Parkdale Ave, Suite 1200a, Manistee, MI 49660 Phone: 231-398-1550 Fax: 231-398-1691 |